September 20, 2014 4:11 PM ET

Life Sciences Tools and Services

Company Overview of MaRS Innovation

Company Overview

MaRS Innovation operates as a commercialization agent for the intellectual properties in the areas of therapeutics, medical device, diagnostic imaging, information, communications, and manufacturing and clean technologies to the inventors in Canada. The company has strategic partnerships with GlaxoSmithKline Inc.; CML HealthCare Inc.; Baxter International Inc.; and Pfizer Inc. MaRS Innovation was incorporated in 2008 and is based in Toronto, Canada.

101 College Street

MaRS Centre

South Tower

Suite 402

Toronto, ON M5G 1L7


Founded in 2008



Key Executives for MaRS Innovation

Chief Executive Officer
Age: 64
Chief Financial Officer and Director
Director of Human Resources
Director of Commercialization
Compensation as of Fiscal Year 2014.

MaRS Innovation Key Developments

Johnson & Johnson Innovation, Janssen Inc. Announce New Collaborations with NEOMED and MaRS Innovation

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health. Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

MaRS Innovation Presents at BioJapan 2013 World Business Forum, Oct-09-2013

MaRS Innovation Presents at BioJapan 2013 World Business Forum, Oct-09-2013 . Venue: Pacifico Yokohama, Yokohama, Japan.

MaRS Innovation Announces New Strategic Partnership with Pfizer Inc

MaRS Innovation announced the formation of a strategic partnership with Pfizer Inc. to advance early-stage technologies related to human health in therapeutics and diagnostics. Through this collaboration, MaRS Innovation and Pfizer will jointly identify investment opportunities emerging from well-validated scientific research discoveries within MaRS Innovation's 16 member institutions, including the University of Toronto and its nine affiliated teaching hospitals. Pfizer will provide funding over a three-year period to support promising individual projects based on their due diligence, which will be leveraged with financial support from MaRS Innovation. Together, it is intended to accelerate the development and validation of healthcare technologies within a highly innovative academic cluster in Canada. The partnership's shared vision for transformative technologies will benefit the health of Canadians and others around the world.

Similar Private Companies By Industry

Company Name Region
Pharmagap Inc. Americas
Convergent Bioscience Ltd. Americas
Pharma Medica Research, Inc. Americas
MedQualis Inc. Americas
PharmaNet Development Group, Inc., Quebec City Facility Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MaRS Innovation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at